Form 8-K - Current report:
SEC Accession No. 0000950170-23-041417
Filing Date
2023-08-10
Accepted
2023-08-10 16:33:46
Documents
14
Period of Report
2023-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prok-20230810.htm   iXBRL 8-K 54251
2 EX-99.1 prok-ex99_1.htm EX-99.1 448259
3 GRAPHIC img22993735_0.jpg GRAPHIC 13089
  Complete submission text file 0000950170-23-041417.txt   660774

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prok-20230810_lab.xml EX-101.LAB 13904
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prok-20230810_pre.xml EX-101.PRE 10232
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prok-20230810.xsd EX-101.SCH 2472
8 EXTRACTED XBRL INSTANCE DOCUMENT prok-20230810_htm.xml XML 4900
Mailing Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103
Business Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103 336-999-7028
PROKIDNEY CORP. (Filer) CIK: 0001850270 (see all company filings)

EIN.: 981586514 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40560 | Film No.: 231160127
SIC: 2836 Biological Products, (No Diagnostic Substances)